SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023915
Filing Date
2016-08-10
Accepted
2016-08-10 16:45:15
Documents
48
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20160630.htm 10-Q 1819456
2 EX-10.2 aimt-ex102_14.htm EX-10.2 33820
3 EX-10.3 aimt-ex103_13.htm EX-10.3 73408
4 EX-10.4 aimt-ex104_59.htm EX-10.4 125549
5 EX-31.1 aimt-ex311_9.htm EX-31.1 18072
6 EX-31.2 aimt-ex312_10.htm EX-31.2 18053
7 EX-32.1 aimt-ex321_8.htm EX-32.1 16992
  Complete submission text file 0001564590-16-023915.txt   5801923

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aimt-20160630.xml EX-101.INS 1273492
9 XBRL TAXONOMY EXTENSION SCHEMA aimt-20160630.xsd EX-101.SCH 26934
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20160630_cal.xml EX-101.CAL 32224
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20160630_def.xml EX-101.DEF 101484
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20160630_lab.xml EX-101.LAB 258321
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20160630_pre.xml EX-101.PRE 189891
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 161822005
SIC: 2834 Pharmaceutical Preparations